Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali()

BACKGROUND: MDR-TB is a major threat to global TB control. In 2015, 580,000 were treated for MDR-TB worldwide. The worldwide roll-out of GeneXpert MTB/RIF(®) has improved diagnosis of MDR-TB; however, in many countries laboratories are unable to assess drug resistance and clinical predictors of MDR-...

Descripción completa

Detalles Bibliográficos
Autores principales: Baya, Bocar, Achenbach, Chad J., Kone, Bourahima, Toloba, Yacouba, Dabitao, Djeneba K., Diarra, Bassirou, Goita, Drissa, Diabaté, Seydou, Maiga, Mamoudou, Soumare, Dianguina, Ouattara, Khadidia, Kanoute, Tenin, Berthe, Gaoussou, Kamia, Youssouf M., Sarro, Yeya dit Sadio, Sanogo, Moumine, Togo, Antieme C.G., Dembele, Bindongo P.P., Coulibaly, Nadie, Kone, Amadou, Akanbi, Maxwell, Belson, Michael, Dao, Sounkalo, Orsega, Susan, Siddiqui, Sophia, Doumbia, Seydou, Murphy, Robert L., Diallo, Souleymane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481646/
https://www.ncbi.nlm.nih.gov/pubmed/30772470
http://dx.doi.org/10.1016/j.ijid.2019.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481646/
https://www.ncbi.nlm.nih.gov/pubmed/30772470
http://dx.doi.org/10.1016/j.ijid.2019.02.004

Ejemplares similares